Insights from the 2024 Salary Survey Report by HealthEconomics.com
Keep your finger on the economic pulse of the RWE, HEOR, and Market Access fields. This session focuses on the latest salary and bonus trends for professionals in the field, including a comprehensive overview of the ways industry, job level, location, demographics, and more factor into compensation.
Podcast Q&A: Clinical Outcomes Assessments and Training
In this episode of tHEORetically Speaking, join Kelly Lipman, Heather Dickerson, and Ryan Murphy from ICON, who answer questions from a recent webinar on the dynamic landscape of clinical outcomes assessments, examining their historical significance, current uses and best practices, and making a case for greater standardization in their implementation.
Navigating the Clinical Outcomes Maze: An Overview of Clinical Outcomes Assessments and Why Training Matters
This webinar delves into the dynamic landscape of COAs, examining their historical use and significance, current uses and best practices, and making a case for greater standardization in their implementation.
Optimizing Real-World Evidence for Maternal and Neonatal Outcomes
Experts from health system innovators (C-Path), patients (PreemieWorld), healthcare payers (Carelon Research (formerly HealthCore) & Elevance Health (formerly Anthem)), and industry (Bayer) provide insights into improving neonatal outcomes using RWE.
How Literature Review Automation and Efficient Processes Streamline RWE HEOR Studies
Literature reviews are an essential element in Real World Evidence (RWE) HEOR studies that impact patient care, policy development, and healthcare decision making.
Podcast Q&A: Literature Reviews and Global Value Dossiers
Experts answer questions on systematic literature review issues that can negatively affect your Global Value Dossiers (GVDs) and how automation can improve your product’s market access.
Finding Value in Linking Real-World Data with Social Determinants of Health
Hear Pamela Landsman-Blumberg and Rick Chapman highlight the importance of SDOH and discuss examples of how claims data and EMR linked with SDOH can inform use cases.
Value-Based Agreements – Are We Going to See More or Less of Them?
Mike Pace, MBA, Pierre Etienne, MD, and Clifton Chow give an insightful and practical webinar on one of the most important areas in pharmaceutical value and market access.
Can Literature Review Automation Improve Healthcare Cost-Effectiveness Analysis and Budget Impact Modeling Outcomes?
Michael Broder, President, PHAR and Jesse Ortendhal, Director of Health Economics, PHAR present on literature review automation in clinic.
